Primary Sclerosing Cholangitis (PSC)

Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.

Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.

Nov 5, 2018

PREsTo: Primary Sclerosing Cholangitis Risk Estimate Tool

By Ethan McConkey, Moderator, @ethanmcconkey


In an effort to better predict the outcomes for Primary Sclerosing Cholangitis (PSC) patients, Mayo Clinic researchers have created a new tool called the Primary Sclerosing Cholangitis Risk Estimate Tool or PREsTo.

The prediction tool was developed and validated through the use of machine learning, a type of artificial intelligence designed to derive patterns in clinical data gathered from several hundred patients with PSC. Of note, the novel prognostic tool outperformed other currently available tools. These findings were published in the journal Hepatology.

Read the news release, and the full study..

Get more information on PREsTo and to calculate your risk score.

Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Primary Sclerosing Cholangitis (PSC) page.

Please login or register to send an invite.